Please assess the completion status of the following clinical trial:

Trial Title: PUVA Versus PUVA + IFN Alpha 2a in Mycosis Fungoides

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Mycosis fungoides Stage Ia Ib IIa~* Written informed consent~* 18-70 y.o., both sex~* No concomitant systemic disease~Exclusion Criteria:~* Pregnant or lactating women~* Fertile women not accepting contraception~* Medical history of melanoma or non melanoma skin cancer~* Concomitant infections~* Immunodeficiency states~* Previous Heart disease~* Respiratory insufficiency~* Chronic RRenal insufficiency~* Chronic hepatopathy~* Epilepsy~* Depression~* Leucocytes \<3000 or neutrophiles \<1000 or thrombocytes \<100000 or hemoglobin \<12 gr/dL or ANA \<1/80~* Treatment with systemic steroids~* Altered thyroid hormones~* Previous resistance to PUVA and/or IFN~* Hypersensitivity to IFN~* Patients under treatment with teophiline and/or dicumarol~* Previous total skin electron beam~* Wash up period less than 3 month for IFN and /or PUVA~* Wash up period less than 1 month for topical treatments

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- A (Type: ACTIVE_COMPARATOR): 8-MOP + UVA x 24 weeks
- B (Type: ACTIVE_COMPARATOR): IFN alone, 2 weeks, 8-MOP + UVA irradiation + IFN, 22 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).